BridgeBio Pharma Inc (BBIO)
27.99
-0.40
(-1.41%)
USD |
NASDAQ |
Dec 27, 16:00
27.99
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Total Long Term Debt (Quarterly): 1.719B for Sept. 30, 2024
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Pfizer Inc | 66.62B |
| Alnylam Pharmaceuticals Inc | 1.024B |
| Cassava Sciences Inc | -- |
| Regeneron Pharmaceuticals Inc | 1.984B |
| Vertex Pharmaceuticals Inc | 0.00 |